Core Viewpoint - The software-as-a-service (SaaS) sector is experiencing significant turmoil due to fears of disruption from artificial intelligence (AI), but these fears may be exaggerated, presenting potential investment opportunities in select software stocks. Group 1: AppLovin - AppLovin has seen a stock price increase of 71% over the past year, yet it currently trades nearly 22% below its 52-week high [2][3] - The company is experiencing rapid revenue growth, particularly from its AI-powered Axon-2 adtech platform, which grew 68% year over year last quarter, enhancing gross margins and profitability [3] - Management plans to expand the platform beyond mobile gaming and introduce a self-serve ad manager, which are expected to be growth catalysts [3] Group 2: Salesforce - Salesforce aims to lead in agentic AI by launching Data Cloud (now Data 360) and acquiring Informatica, positioning itself as the master record of organizational data [4][5] - The stock has decreased by about 28% over the past year, attributed to concerns over slowing core growth and increased competition, making it relatively cheap with a forward P/S multiple below 5 and a forward P/E ratio of 18 [5] Group 3: Workday - Workday claims to have the "largest and cleanest" human resource and finance database, which is crucial in the AI era [6] - The company is introducing AI agents and tools for finance, legal, and HR, and has acquired Paradox to enhance its hiring process [7] - Workday's stock has fallen nearly 24% over the past year, but it is trading at a forward P/S ratio below 5 and a forward P/E of 18, indicating it is undervalued [7] Group 4: GitLab - GitLab operates a DevSecOps platform and has seen its stock decline about 45% over the past year due to fears that AI may reduce the need for coders [9] - Despite these concerns, the company has consistently grown its revenue by 25% or more, driven by an increasing enterprise customer count [10] - The launch of its Duo Agent solution and a new hybrid pricing model could serve as growth catalysts, with the stock trading at a forward P/S multiple under 5.5 [10] Group 5: UiPath - UiPath's stock has decreased about 24% from its 52-week high, but the company is transitioning to become an AI orchestration platform [11] - The Maestro platform is designed to manage AI agents and software bots, addressing the need for governance and compliance as AI agents proliferate [13] - The stock is attractively valued, with a forward P/S multiple below 5 and a forward P/E around 20 [14]

Core Viewpoint - The investment strategies have shown positive returns for the year, with a focus on long-term performance over short-term results [2][5]. Performance Summary - Large Cap Composite (Gross) returned -1.4% QTD, 8.5% YTD, and 10.4% annualized since inception [3][22]. - Small Cap Composite (Gross) returned 3.4% QTD, 10.3% YTD, and 8.3% annualized since inception [3][31]. - Focus Composite (Gross) returned 0.2% QTD, 7.5% YTD, and 14.3% annualized since inception [3][36]. - All Cap Composite (Gross) returned 1.5% QTD, 11.5% YTD, and 11.1% annualized since inception [3][53]. Market Environment - The current market resembles the late 1990s, with concerns about overvaluation and a focus on AI-related stocks [5][6][7]. - AI is seen as a transformative technology, similar to the Internet, but caution is advised regarding valuations [7][9]. Investment Strategy - The company emphasizes buying only those companies with stable values, often waiting for them to become discounted enough for investment [10][12]. - The portfolio has shifted towards more healthcare and insurance-related businesses, with a focus on smaller companies outside the top 10 largest market capitalizations [11][12]. Notable Holdings - Medpace (MEDP) has shown significant growth, with a stock price increase of over 73% for the year, driven by strong free cash flow and share repurchases [13][14]. - Ryan Specialty Holdings Inc. is highlighted for its robust growth and stable margins, despite facing a short-term pricing cycle [24][25][38]. - TransUnion is recognized for its strong operating margins and successful diversification beyond credit reports [26][38]. Performance Contributors and Detractors - Alphabet Inc. and Salesforce Inc. were significant contributors to performance, while CoStar Group and Microsoft Corporation were notable detractors [37][46]. - Fiserv Inc. was a material detractor due to downward guidance and strategic shifts in its business model [30][46]. Market Trends - The small-cap sector has lagged behind large-cap returns, presenting potential opportunities for investment as it is often overlooked [15]. - The dominance of large-cap stocks in market returns continues, with the top 10 S&P 500 stocks accounting for over 50% of its return in 2025 [16].

Core Viewpoint - The software sector, particularly Software as a Service (SaaS) companies, is facing significant challenges due to the emergence of AI tools like Claude Code, which can drastically reduce the time required for software development and potentially disrupt traditional revenue models based on annual licensing [2][5][4]. Group 1: Impact of AI on Software Companies - Claude Code has demonstrated the ability to recreate a year's worth of work in just one hour, raising concerns for SaaS firms that rely heavily on yearly licensing for revenue [2]. - The introduction of Claude Code has shifted the perception of software from being an AI beneficiary to an AI victim, as it automates entire workflows and reduces the need for expensive software licenses [5][4]. - Major software companies, including Salesforce, DocuSign, and Atlassian, are at risk of losing revenue due to the capabilities of AI tools like Claude Code [4][5]. Group 2: Company-Specific Challenges - Salesforce, the original SaaS company, faces the risk of losing high-margin license revenue as AI agents can perform the work of hundreds of human representatives [6][5]. - DocuSign, which thrived during the pandemic, is now at risk of obsolescence as e-signature solutions are increasingly bundled into larger platforms like Microsoft 365, and AI agents may bypass its offerings entirely [8][9]. - Atlassian, known for its workflow tools, risks redundancy of its platforms as AI agents simplify workflow integration, potentially impacting its bottom line significantly [11]. Group 3: Stock Performance and Market Sentiment - Adobe shares have declined over 25% in the last 12 months, reflecting broader struggles within the software sector [1]. - Salesforce shares dropped 7% in a single session following negative news about Adobe and Claude Code, indicating heightened selling pressure [7]. - DocuSign shares have reached a new 52-week low, with strong resistance at the 50-day simple moving average, suggesting ongoing challenges in regaining investor confidence [10]. - Atlassian shares have lost more than 15% in the last ten days, with a bearish MACD crossover indicating a potential continuation of the downtrend [12].

Group 1 - Salesforce, Inc. (NYSE:CRM) is projected to have strong earnings growth over the next 5 years, with Wolfe Research maintaining an 'Outperform' rating and a price target of $350, indicating a potential upside of approximately 50% [1] - The company's AI portfolio is gaining positive momentum, with Agentforce becoming more integrated into the user interface, offering proactive agent-powered suggestions within workflows [2] - Early deployments of Agentforce focus on internal use cases such as meeting setup, CRM data entry, enterprise search, customer service chatbots, and sales development functions [3] Group 2 - Barclays raised the price target for Salesforce, Inc. to $338 from $330, maintaining an 'Overweight' rating, which is slightly above the consensus 1-year median price target of $335, suggesting an upside potential of about 44% [4] - Salesforce is a California-based provider of customer relationship management (CRM) technology, connecting companies and customers through offerings like Agentforce, Data Cloud, Industries AI, and Slack [5]

Market Overview - The global Cognitive Analytics Market was valued at USD 7.90 billion in 2025 and is projected to reach USD 81.46 billion by 2033, with a CAGR of 33.99% from 2026 to 2033 [1] - The U.S. Cognitive Analytics Market was valued at USD 2.17 billion in 2025 and is expected to grow to USD 22.03 billion by 2033, with a CAGR of 33.61% from 2026 to 2033 [3] Growth Drivers - The market is expanding due to increasing demand for data-driven decision-making, real-time insights, and the growing acceptance of AI and machine learning across various industries [1][3] - Factors contributing to the U.S. market growth include high AI adoption, advanced digital infrastructure, robust business expenditures, and cloud integration [3] Segmentation Analysis By Enterprise Type - Large Enterprises held a 61% market share in 2025, driven by large data volumes and complex business processes, while small and medium enterprises are expected to grow the fastest from 2026 to 2033 due to lower entry barriers from cloud-based solutions [4] By Application - Customer Management accounted for 31% of the market share in 2025, focusing on enhancing customer experience and retention, while Fraud Detection and Security is anticipated to grow the fastest from 2026 to 2033 due to increasing cyber threats [5] By End-User - The BFSI sector dominated with a 28% share in 2025, relying heavily on advanced analytics for fraud prevention and risk assessment, while Retail is expected to experience the fastest growth from 2026 to 2033 as companies leverage cognitive analytics for demand forecasting and personalized promotions [6][7] By Deployment - Cloud deployment led with a 64% market share in 2025 and is projected to grow at the fastest rate from 2026 to 2033, attributed to its scalability and cost efficiency [8] Regional Insights - North America held the largest revenue share of approximately 38% in 2025, benefiting from early AI adoption and a strong presence of major technology providers [9] - The Asia Pacific region is expected to grow at the fastest CAGR of about 15.22% from 2026 to 2033, driven by rapid digital transformation and increasing AI investments [10] Market Trends - There is a rising enterprise focus on data-driven decision-making using AI-powered insights, which enhances operational efficiency and competitive advantage through real-time analysis of consumer behavior and market trends [11] Key Players - Major companies in the cognitive analytics market include Google LLC, Oracle Corporation, IBM Corporation, Microsoft Corporation, and Amazon Web Services, among others [13]

Core Viewpoint - Salesforce, Inc. is recognized as a significant AI stock on Wall Street, with Goldman Sachs initiating coverage with a "Buy" rating and a price target of $330, driven by the anticipated success of its AI platform, Agentforce [1]. Group 1: Agentforce and Revenue Impact - Agentforce is an AI-powered platform that enables the creation and management of proactive, autonomous agents, positioning Salesforce favorably for the adoption of agentic AI in sales and services [2]. - The firm expects a 4% tailwind to Platform and Other revenue over the next 12 to 18 months, potentially leading to a revenue inflection as early as 2026 [3]. - Over the FY26-FY30 period, Agentforce is projected to contribute a 2% tailwind to overall business performance, despite ongoing share loss in Commerce and Marketing Cloud [4]. Group 2: Market Position and Investment Considerations - Salesforce has gained popularity as a cloud-based CRM company following the launch of Agentforce, which is expected to catalyze stock outperformance through increased customer momentum [4]. - While Salesforce is viewed as a potential investment, there are opinions that other AI stocks may offer greater upside potential with less downside risk [5].

Core Insights - Viz.ai has launched a new real-time clinical intelligence service for Salesforce's Agentforce Life Sciences, integrating data from nearly 2,000 hospitals covering 230 million lives in the U.S. [1] - The collaboration aims to streamline patient journeys and enhance clinician education by providing timely, actionable insights at the point of care [2][3]. Group 1: Service Features - The new service enables intelligent, closed-loop workflows that guide actions across commercial, medical, and patient support teams [2]. - It addresses challenges in the life sciences sector by unifying clinical and customer contexts, closing information gaps, and coordinating teams effectively [3]. - The Agentforce Life Sciences platform includes a library of ready-to-use skills, allowing for customization and extension of agent capabilities [4]. Group 2: Market Impact - The partnership between Viz.ai and Salesforce is positioned to transform the pharmaceutical go-to-market strategy into a continuous, point-of-care operating system [5]. - Over the past year, more than 110 life science companies have adopted Agentforce Life Sciences, indicating strong market interest and potential for growth [4]. - The integration of Viz.ai's real-time clinical signals with Agentforce Life Sciences aims to improve clinician engagement and patient onboarding processes [6]. Group 3: Company Background - Viz.ai is recognized as a leader in AI-powered care coordination and clinical workflow solutions, trusted by top life sciences companies and deployed in nearly 2,000 hospitals across the U.S. [8]. - The company has been awarded CMS reimbursement for its AI solutions and has been ranked as the 1 Healthcare AI Platform by hospitals and health systems [8].

Core Insights - Salesforce has activated the World Economic Forum's institutional knowledge using Agentforce 360 to support over 3,000 influential leaders at the 2026 World Economic Forum Annual Meeting [1] Group 1 - The Forum has launched a new proactive, high-precision concierge app named "EVA" [1] - EVA is built on the Agentforce 360 Platform, which is Salesforce's agentic platform [1] - The app aims to empower attendees to move beyond traditional interactions [1]

Core Viewpoint - Salesforce's stock is experiencing a significant decline, dropping approximately 10% year-to-date, primarily due to concerns over competition from AI technologies like OpenAI's ChatGPT [1] Group 1: Stock Performance - Salesforce shares fell 24% in 2025, contrasting with a 14% rise in Microsoft shares and a 36% increase in the Nasdaq Composite [2] - The stock is currently the worst performer in the Dow Jones Industrial Average [1] Group 2: Analyst Insights - JP Morgan analyst Mark Murphy indicated that Salesforce is in a complex transition period lasting 12-18 months, with internal metrics stabilizing but not necessarily translating into immediate improvements in revenue and other key metrics [2] - Murphy predicts that Salesforce shares will not rebound until the second half of the year [3] Group 3: Company Initiatives - Salesforce is actively working to improve its stock performance, including showcasing its AI initiative, Agentforce, at the Dreamforce event, which has reportedly driven productivity for clients like PepsiCo and Dell [3] - The company raised its fiscal 2026 revenue and adjusted profit forecasts in December [3] Group 4: Financial Metrics - Annual recurring revenue (ARR) for Agentforce surpassed half a billion dollars in the third fiscal quarter, marking a more than fourfold increase from the previous year [4] Group 5: Leadership and Relationships - CEO Marc Benioff has been strengthening ties with the Trump administration, as Salesforce conducts significant business with the government [4] - Benioff's controversial comments regarding deploying National Guard troops in San Francisco were perceived as supportive of Trump, although he later moderated his stance [5] Group 6: Market Challenges - The stock remains difficult to buy, even at a discount, until Salesforce demonstrates profitability from Agentforce and meets its ambitious FY30 guidance [6] - The software sector is undergoing a valuation reset due to the impact of AI, complicating the achievement of optimistic guidance [6]

Core Insights - L1 Capital International Fund's fourth-quarter 2025 investor letter emphasizes the importance of valuation analysis for AI-focused investments, indicating that mere conviction in AI is insufficient for successful outcomes [1] - The fund achieved a return of 2.2% for the quarter and 9.8% for the year 2025, underperforming the benchmark MSCI World Net Total Return Index, which returned 2.5% and 12.4% respectively [1] Company-Specific Insights - Salesforce, Inc. (NYSE:CRM) was highlighted as a key investment, with a one-month return of -7.09% and a 52-week loss of 25.13%, closing at $239.57 per share with a market capitalization of $228.071 billion as of January 14, 2026 [2] - The fund initiated a position in Salesforce during the December 2025 quarter, citing its leadership in customer relationship management software and a highly profitable business model, despite a share price decline of over 35% from its late-2024 peak [3] - Salesforce is expected to achieve high single-digit revenue growth and earnings per share growth in the teens over the medium term, with the fund viewing it as an attractive risk-adjusted return opportunity [3] - In the third quarter of 2026, Salesforce reported revenue of $10.26 billion, reflecting a year-over-year increase of 9% and 8% in constant currency, although some analysts believe other AI stocks may offer greater upside potential [4]